Related references
Note: Only part of the references are listed.Serum neurofilament light levels in normal aging and their association with morphologic brain changes
Michael Khalil et al.
NATURE COMMUNICATIONS (2020)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study (vol 18, pg 1103, 2019)
E. L. van der Ende et al.
LANCET NEUROLOGY (2020)
Neurofilament light chain as a biomarker in neurological disorders
Lorenzo Gaetani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
Carlo Wilke et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases
Ross W. Paterson et al.
NATURE REVIEWS NEUROLOGY (2019)
Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
Quan-Fu Li et al.
MOLECULAR NEURODEGENERATION (2019)
Physiological and pathophysiological characteristics of ataxin-3 isoforms
Daniel Weishaeupl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen
Benedikt Winter et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Emma L. van der Ende et al.
LANCET NEUROLOGY (2019)
Diagnostic and Prognostic Performance of Neurofilaments in ALS
Koen Poesen et al.
FRONTIERS IN NEUROLOGY (2019)
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
Raygene Martier et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias
James M. Joers et al.
ANNALS OF NEUROLOGY (2018)
Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice
Hayley S. McLoughlin et al.
ANNALS OF NEUROLOGY (2018)
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study
Carlo Wilke et al.
JOURNAL OF NEUROLOGY (2018)
Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes
Isaac M. Adanyeguh et al.
NEUROIMAGE-CLINICAL (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M. Byrne et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes
Biswarathan Ramani et al.
HUMAN MOLECULAR GENETICS (2017)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Lauren M. Byrne et al.
LANCET NEUROLOGY (2017)
Polyglutamine spinocerebellar ataxias - from genes to potential treatments
Henry L. Paulson et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3
Jonasz J. Weber et al.
BRAIN (2017)
Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis
Patrick Weydt et al.
ANNALS OF NEUROLOGY (2016)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
Carlo Wilke et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study
Heike Jacobi et al.
LANCET NEUROLOGY (2015)
In Vivo Neurometabolic Profiling in Patients With Spinocerebellar Ataxia Types 1, 2, 3, and 7
Isaac M. Adanyeguh et al.
MOVEMENT DISORDERS (2015)
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
Pawel M. Switonski et al.
NEUROBIOLOGY OF DISEASE (2015)
A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript
Biswarathan Ramani et al.
HUMAN MOLECULAR GENETICS (2015)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Ricarda A. L. Menke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6
Sophie Tezenas du Montcel et al.
JOURNAL OF MEDICAL GENETICS (2014)
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Tobias Skillback et al.
NEUROLOGY (2014)
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6
Kathrin Reetz et al.
BRAIN (2013)
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data (vol 12, pg 650, 2013)
H. Jacobi et al.
LANCET NEUROLOGY (2013)
Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
Huu Phuc Nguyen et al.
PLOS ONE (2013)
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
Udo Rueb et al.
PROGRESS IN NEUROBIOLOGY (2013)
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
Heike Jacobi et al.
LANCET NEUROLOGY (2013)
Toward understanding Machado-Joseph disease
Maria do Carmo Costa et al.
PROGRESS IN NEUROBIOLOGY (2012)
Targeted Genome Modification in Mice Using Zinc-Finger Nucleases
Iara D. Carbery et al.
GENETICS (2010)
Scale for the assessment and rating of ataxia -: Development of a new clinical scale
T. Schmitz-Huebsch et al.
NEUROLOGY (2006)
Share Paper
